July 14, 2005 17:12 ET

Ceapro announces officer appointment

EDMONTON, July 14 - Ceapro Inc. (TSX VENTURE:CZO) today announced the
appointment of Mr. Shawn McMillan as Corporate Secretary. Shawn will continue
to serve as Controller of Ceapro Inc.

"This is an exciting time for Ceapro as our business continues to expand
and we are pleased to have Shawn play an expanded role on our team," said
Dr. Mark Redmond, Ceapro's President and CEO. "We are focused on growth, and
this year looks promising as we roll out new products such as CeaProve™,
our diabetes management technology."

Shawn earned his Bachelor of Commerce degree in Accounting from the
University of Alberta in 2002. Articling with both Collins Barrow Chartered
Accountants and Deloitte and Touche LLP, he obtained his Chartered Accountant
designation in 2005. Shawn joined Ceapro as Controller in April 2005.

About Ceapro Inc.

Ceapro Inc., an innovation-driven biotechnology company, develops and
commercializes organic products for medical, cosmetic, and animal health
industries using proprietary technology and natural, renewable resources.
Based in Edmonton, Alberta, Ceapro is one of Alberta Venture's Fastest Growing
Companies for 2004 and 2005 and is one of Profit Magazine's Next 100
Companies. Ceapro is also the recipient of the ASTech Award for Outstanding
Commercial Achievement for companies with annual sales of less than
$25 million. Ceapro's shares trade on the TSX Venture Exchange under the
symbol CZO. To learn more about Ceapro, log on to our website at
www.ceapro.com. Shares Outstanding: 36,355,950, Recent Close: $0.28.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this news release.

This release may contain forward-looking statements. Various factors
could cause actual results to differ materially from those projected in
forward-looking statements. Although the Company believes that the forward-
looking statements contained herein are reasonable, it can give no assurance
that the Company's expectations are correct. All forward-looking statements
are expressly qualified in their entirety by this cautionary statement.

Contact Information

  • Dr. Mark Redmond, President, Ceapro Inc.,
    Telephone: (780) 421-4555